证券记录 · 已归档季度
CADL
Candel Therapeutics, Inc. · Healthcare · Biotechnology
11被追踪持有人
+1Δ持有人
14.70M持有股份
$74.37M报告持仓市值
+3新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +10.0% ·
股份流向 +4.5% ·
净新建仓位 +9.1%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 64 | +11 | 29.28M | $301.40M | +14 | −3 |
| Q1 2026 | 56 | +7 | 21.92M | $107.44M | +12 | −5 |
| Q4 2025 | 49 | -3 | 17.41M | $98.31M | — | −3 |
| Q3 2025 | 14 | 0 | 15.17M | $77.37M | +2 | −2 |
| Q2 2025 | 11 | +1 | 14.70M | $74.37M | +3 | −2 |
| Q1 2025 | 7 | +2 | 1.74M | $9.82M | +2 | — |
| Q4 2024 | 5 | 0 | 1.36M | $11.81M | — | — |
| Q3 2024 | 4 | +1 | 482.85K | $3.35M | +2 | −1 |
| Q2 2024 | 3 | — | 435.83K | $2.70M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 8.23M | — | $41.66M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 8.23M | — | $41.66M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 8.23M | — | $41.66M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 2.30M | — | $11.65M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 2.30M | — | $11.65M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 2.30M | — | $11.65M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 2.30M | — | $11.65M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 2.30M | — | $11.65M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 2.30M | — | $11.65M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (被动) | 1.79M | — | $9.04M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 1.79M | — | $9.04M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 1.79M | — | $9.04M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Geode Capital Management ✦ (被动) | 903.97K | +31.5% | $4.57M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (被动) | 903.97K | +31.5% | $4.57M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (被动) | 651.98K | +15.7% | $3.30M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 369.19K | 新增 | $1.87M | 0.0% | New | 1 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 163.60K | 新增 | $827,816 | 0.0% | New | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 161.48K | -31.2% | $817,088 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Marshall Wace ✦ | 161.48K | -31.2% | $817,088 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Wellington Management ✦ | 86.25K | 新增 | $436,410 | 0.0% | New | 1 | SEC ↗ |
| 21 | Wellington Management ✦ | 86.25K | 新增 | $436,410 | 0.0% | New | 1 | SEC ↗ |
| 22 | Wellington Management ✦ | 86.25K | 新增 | $436,410 | 0.0% | New | 1 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 19.64K | +60.0% | $100,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 19.26K | -8.4% | $97,461 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 19.26K | -8.4% | $97,461 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 19.26K | -8.4% | $97,461 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Two Sigma Investments | $1.87M | 0.0% |
| Renaissance Technologies | $827,816 | 0.0% |
| Wellington Management | $436,410 | 0.0% |
| Wellington Management | $436,410 | 0.0% |
| Wellington Management | $436,410 | 0.0% |
已清仓
| Millennium Management | $1.18M | 曾为 0.0% |
| Citadel Advisors | $54,443 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 113 持有人, 43.40M 股份, $212.35M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 17
Tyagarajan Seshu
Officer · 7.00K 股 · $84,000
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 27
SC 13G — BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据